Area of research
Physiology · Pharmacology
Research interest
Research interests include Neuroscience, Biology, PI3K/AKT/mTOR pathway, Alzheimer's disease, Neurodegeneration, and Autophagy.
Chronic Dyrk1 Inhibition Delays the Onset of AD-Like Pathology in 3xTg-AD Mice
Necroptosis activation in Alzheimer's disease
Genetic reduction of Nrf2 exacerbates cognitive deficits in a mouse model of Alzheimer’s disease
Dyrk1 inhibition improves Alzheimer's disease‐like pathology
Reducing Ribosomal Protein S6 Kinase 1 Expression Improves Spatial Memory and Synaptic Plasticity in a Mouse Model of Alzheimer's Disease
The mammalian target of rapamycin at the crossroad between cognitive aging and Alzheimer’s disease
Aberrant intracellular localization of H3k4me3 demonstrates an early epigenetic phenomenon in Alzheimer's disease
Genetic Reduction of Mammalian Target of Rapamycin Ameliorates Alzheimer's Disease-Like Cognitive and Pathological Deficits by Restoring Hippocampal Gene Expression Signature
How longevity research can lead to therapies for Alzheimer's disease: The rapamycin story
Administration of a selective β2 adrenergic receptor antagonist exacerbates neuropathology and cognitive deficits in a mouse model of Alzheimer's disease
Genetic suppression of β2-adrenergic receptors ameliorates tau pathology in a mouse model of tauopathies
<scp>mTOR</scp> regulates tau phosphorylation and degradation: implications for Alzheimer's disease and other tauopathies
Autophagic/lysosomal dysfunction in Alzheimer’s disease
Mammalian target of rapamycin hyperactivity mediates the detrimental effects of a high sucrose diet on Alzheimer's disease pathology
Accumulation of C-terminal fragments of transactive response DNA-binding protein 43 leads to synaptic loss and cognitive deficits in human TDP-43 transgenic mice